Tenders Are Invited For Medical Equipments – Synthesis Systems For The Production Of Radioactively Labeled Medicines

Medical Equipments – Synthesis Systems For The Production Of Radioactively Labeled Medicines. Nuclear Medicine In Bonn Currently Occupies A Leading Position Nationally And Internationally. With Fundamental Adjustments To The Existing Building Stock, An Optimal Process Can Be Achieved By Linking The Existing Functional Areas. This Allows The Nuclide Laboratory To Ensure A Long-Term Supply Of The Most Modern Radioactively Labeled Substances For Diagnostics And Therapy Of Patients. The New Hot Laboratory Also Enables The Development And Use Of New Radioactive Drugs For Treatment. Module A) Is Used For The Automated Production Of Radioactively Labeled Drugs For Nuclear Medicine Diagnostics And Therapy. The System Carries Out The Individual Manufacturing Steps Independently In A Closed System, Thereby Contributing To Consistently High Manufacturing Quality And Protecting Personnel From Radioactive Radiation. The System Enables The Reproducible Production Of Established Standard Radiopharmaceuticals And Forms A Central Part Of Routine Patient Care As Well As The Development Of New Applications. Module B) Is Also Used For The Automated Production Of Radioactively Labeled Drugs. For Certain, Especially Complex, Radioactively Labeled Drugs, Additional Chromatographic Purification Is Required. For This Purpose, The System Has An Integrated Purification System (Semi-Preparative Hplc) That Separates The Desired Radioactive Agent From Secondary And Starting Materials. This Allows The Drug To Be Produced In The Purity Required For Later Use. The Combination Of Production And Purification In One System Enables A Safe And Standardized Production Process. The Scope Of The Contract Volume Is Shown In The Tender Documents.